Ventilator-associated pneumonia involving Aspergillus flavus in a patient with coronavirus disease 2019 (COVID-19) from Argentina
Norma Fernández, Diego H. Cáceres, Karlyn D. Beer, Célica Irrazábal, Ghilka Delgado, Luciana Farías, Tom Chiller, Paul E. Verweij, Daniel Stecher
Abstract
Coronavirus disease 2019 (COVID‐19), caused by the novel coronavirus SARS-CoV-2, emerged in Wuhan, China, in December 2019 and rapidly spread around the world. Invasive aspergillosis has been reported as a complication of severe influenza pneumonia among intensive care patients. Similarities between COVID-19 and influenza pneumonia, together with limited published case series, suggest that aspergillosis may be an important complication of COVID-19. This report describes a case of ventilator-associated pneumonia involving Aspergillus flavus in a patient with COVID-19 from Buenos Aires, Argentina.
Topics & Concepts
MedicinePneumoniaAspergillosisCoronavirus disease 2019 (COVID-19)CoronavirusComplicationAspergillus flavusIntensive care medicineDiseasePandemicVirologyImmunologyInfectious disease (medical specialty)Internal medicineMicrobiologyBiologyAntifungal resistance and susceptibilityAntibiotic Use and ResistanceNosocomial Infections in ICU